Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.

Heiko Schöder(Memorial Sloan Kettering Cancer Center), Johannes Czernin(University of California, Los Angeles), Joubin Meta, Peter E. Valk(University of California, Los Angeles), Cecilia Yap, Michael E. Phelps(National Academy of Engineering), Jyotsna Rao, J.W. Sayre, Maryam Ariannejad
PubMed
August 1, 2001
Cited by 142

Related Papers

Quantitation in Positron Emission Computed Tomography
|Journal of Computer Assisted Tomography|1979|1.2k
Systems Biology and New Technologies Enable Predictive and Preventative Medicine
|Science|2004|1.1k
Positron Emission Tomography in Evaluation of Dementia
|JAMA|2001|952
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
|Proceedings of the National Academy of Sciences|2000|798
PET of Brain Amyloid and Tau in Mild Cognitive Impairment
|New England Journal of Medicine|2006|737